Immunohistochemical demonstration of fibrin II in gastric cancer tissue

Polish Journal of Pharmacology

Volumn 48, Issue 2, 1996, Pages 229-232

  Wojtukiewicz, Marek Z ^a   Zimnoch, Lech ^a   Jaromin, Jacek ^a   Kłoczko, Janusz ^a   Bielawiec, Michał ^a   Matuszewska, Elwira A ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Coagulation; Fibrin; Gastric cancer; Thrombin

Indexed keywords

FIBRIN;

ANGIOGENESIS; CELL MEMBRANE; CLINICAL ARTICLE; CONFERENCE PAPER; FIBRIN DEPOSITION; FIBRINOLYSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; STOMACH CANCER; TISSUE DISTRIBUTION;

CARCINOMA; FIBRIN; FIBRINOGEN; FIBRINOPEPTIDE B; HUMANS; IMMUNOHISTOCHEMISTRY; STOMACH NEOPLASMS;

EID: 0030056805     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Bick R. L.: Coagulation abnormalities in malignancy: a review. Semin. Thromb. Hemostasis, 1992, 18, 353-372.
2. Brown L. F., Berse B., Jackman R. W., Tognazzi K., Manseau E. J., Senger D. R., Dvorak H. F.: Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in adenocarcinomas of the gastrointestinal tract. Cancer Res., 1993, 53, 4727-4735.
3. 2-terminal fragments derived from fibrinogen and fibrin. Mol. Immunol., 1983, 20, 1191-1200.
4. 2-terminal region of fibrin. Mol. Immunol., 1984, 21, 89-94.
5. 125I-fibrinogen kinetics and fibrinopeptide A in patients with disseminated neoplasias. Blood, 1982, 60, 381-388.
6. Olander J. V., Bremer M. E., Marasa J. C., Feder J.: Fibrin enhanced endothelial cell organization. J. Cell. Physiol., 1985, 125, 1-9.
7. Rickles F. R., Edwards R. L.: Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood, 1983, 62, 14-31.
8. Sato Y., Mukai K., Watanabe S., Goto M., Shimosato Y.: The AMeX method. A simplified technique of tissue processing and paraffin embedding with improved preservation of antigens for immunostaining. Amer. J. Pathol., 1986, 125, 431-435.
9. Trousseau A.: Phlegmasia alba dolens. In: Clinique Medicale de l'Hôtel-Dieu de Paris. New Sydenham Society, London, 1865, 3, 94.
10. Tsopanoglou N. E., Pipili-synetos E., Maragoudakis M. E.: Thrombin promotes angiogenesis by a mechanism independent of fibrin formation. Amer. J. Physiol. Cell. Physiol., 1993, 264, 33, C1302-C1307.
11. Wojtukiewicz M. Z., Zacharski L. R., Memoli V. A., Kisiel W., Kudryk B. J., Rousseau S. M., Stump D. C.: Abnormal regulation of coagulation/fibrinolysis in small cell carcinoma of the lung. Cancer, 1990, 65, 481-485.
12. Wojtukiewicz M. Z., Zacharski L. R., Memoli V. A., Kisiel W., Kudryk B. J., Rousseau S. M., Stump D. C.: Fibrinogen-fibrin transformation in situ in renal cell carcinoma. Anticancer Res., 1990, 10, 579-582.
13. Wojtukiewicz M. Z., Zacharski L. R., Memoli V. A., Kisiel W., Kudryk B. J., Rousseau S. M., Stump D. C.: Malignant melanoma. Interaction with coagulation and fibrinolysis pathways in situ. Amer. J. Clin. Pathol., 1990, 93, 516-521.
14. Wojtukiewicz M. Z., Tang D. G., Ciarelli J. J., Nelson K. K., Walz D. A., Diglio C. A., Mammen E. E., Honn K. V.: Thrombin increases the metastatic potential of tumor cells. Int J. Cancer, 1993, 54, 793-806.
15. Wojtukiewicz M. Z., Tang D. G., Ben-josef E., Renaud C., Walz D. A., Honn K, V.: Solid tumor cells express functional "tethered ligand" thrombin receptor. Cancer Res., 1995, 55, 698-704.
16. Yoda Y., Abe T.: Fibrinopeptide A (FPA) level and fibrinogen kinetics in patients with malignant disease. Thromb. Haemost., 1981, 46, 706-709.
17. Zacharski L. R., Memoli V. A., Rousseau S. M.: Thrombin-specific sites of fibrinogen in small cell carcinoma of the lung. Cancer, 1988, 62, 299-302.
18. Zacharski L. R., Wojtukiewicz M. Z., Costantini V., Ornstein D. L., Memoli V. A.: Pathways of coagulation/fibrinolysis activation in malignancy. Semin. Thromb. Hemost., 1992, 18, 104-116.